Mettler Toledo International Inc/: Form 10-Q for the period ended Mar 31, 2022
Filed with the SEC on May 6, 2022 and accepted by EDGAR at May 6, 2022, 13:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-01-01 to 2022-03-31 | $897.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Gross profit | 3 months2022-01-01 to 2022-03-31 | $519.6m | us-gaap:GrossProfit |
| Research and development | 3 months2022-01-01 to 2022-03-31 | $43.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-01-01 to 2022-03-31 | $235.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months2022-01-01 to 2022-03-31 | $11.3m | us-gaap:InterestExpense |
| Income tax | 3 months2022-01-01 to 2022-03-31 | $39.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-01-01 to 2022-03-31 | $174.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-01-01 to 2022-03-31 | $7.55 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-01-01 to 2022-03-31 | $7.64 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-01-01 to 2022-03-31 | 23,040,231 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2022-01-01 to 2022-03-31 | $90.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2022-01-01 to 2022-03-31 | $19.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2022-01-01 to 2022-03-31 | $275.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2022-03-31 | $1.31bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-03-31 | $3.36bn | us-gaap:Assets |
| Current liabilities | At period end2022-03-31 | $1.09bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-03-31 | $3.27bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-03-31 | $1.77bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2022-03-31 | $84.6m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2022-03-31 | 22,680,305 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001037646-22-000015. Last ingested by Listed: Nov 13, 2026, 02:43 ET. Listed shows no prices and gives no investment advice.